Loading…
Loading…
TCNNF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for TCNNF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for TCNNF and 80,000+ other tickers.
See exactly how TCNNF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TCNNF and 80,000+ other tickers.
Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules…
With the continued growth and expansion of the cannabis industry, companies are witnessing another shift. Between the USA and Canada, more companies are focused on better branding and marketing attached to better quality products. Right now, in legal cannabis, it is the battle of genetics and who has what and who is inside their legal facilities. As cannabis becomes more mainstream, consumers, like anything else, want reliable products from top brands.
Trulieve Cannabis Corp. (NYSE:TRLV) rang in a new era for the U.S. cannabis industry on Wednesday, becoming the first American marijuana company to list on a major U.S. stock exchange.
The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate operators continue strengthening their positions across key U.S. markets. Investors searching for cannabis exposure may want to focus on companies with strong retail footprints and improving financial performance.
TALLAHASSEE, Fla., June 9, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced that its Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase up to the lesser of (i) $50 million in aggregate value, and (ii) 8,495,038 subordinate voting shares of the Company (being five percent (5%) of the Company's issued and outstanding subordinate voting shares as at June 8, 2026) over a 12-month period.
Green Thumb Industries and Tilray are in a strong position to benefit from the reclassification of cannabis as a Schedule III drug. Tilray is well positioned to expand its U.S. operations.